2.72
-0.03 (-1.09%)
| Previous Close | 2.75 |
| Volume | 63,111 |
| Price / Earnings (Forward) | 73.53 |
| Price / Sales | 4.17 |
| Price / Book | 3.78 |
| 52 Weeks Range |
| Profit Margin | 9.00% |
| Operating Margin (TTM) | 7.88% |
| Diluted EPS (TTM) | 0.050 |
| Quarterly Revenue Growth (YOY) | 17.50% |
| Quarterly Earnings Growth (YOY) | 58.20% |
| Total Debt/Equity (MRQ) | 4.85% |
| Current Ratio (MRQ) | 5.42 |
| Operating Cash Flow (TTM) | 34.93 M |
| Levered Free Cash Flow (TTM) | 24.70 M |
| Return on Assets (TTM) | 3.24% |
| Return on Equity (TTM) | 9.09% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (AU) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | NANOSONICS FPO [NAN] | - | - |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.19 |
|
Nanosonics Ltd is engaged in the manufacturing, service and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories; and research, development and commercialization of infection control and decontamination products and related technologies. Its products are divided into two categories: Ultrasound Reprocessing solutions, and Endoscope Reprocessing solutions. The company operates in a single segment being the healthcare equipment segment which manufactures and commercializes infection control and decontamination products and related technologies. Geographically, it operates in Australia, North America, Europe and Middle East, and Asia Pacific. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 17.03% |
| % Held by Institutions | 49.91% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |